SECURITY AGREEMENTSecurity Agreement • September 14th, 2016 • Protea Biosciences Group, Inc. • Pharmaceutical preparations • Delaware
THIS SECURITY AGREEMENT (this “Agreement”) is made as of September 8, 2016 (the “Effective Date”) by and among (A) Protea Biosciences Group, Inc., a corporation organized under the laws of the State of Delaware (“PRGB” or the “Parent”); (B) Protea Biosciences, Inc., a corporation organized under the laws of the State of Delaware (the “Subsidiary”); and (C) ____________ (the “Secured Party”). The Parent and the Subsidiary, which is a wholly-owned subsidiary of the Parent, are individually and collectively referred to herein as the “Debtor”. The Debtor and the Secured Party are hereinafter sometimes individually referred to as a “Party” and collectively as the “Parties.”
ContractNote • September 14th, 2016 • Protea Biosciences Group, Inc. • Pharmaceutical preparations • New York
THIS NOTE HAS NOT BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS AS EVIDENCED BY A LEGAL OPINION OF COUNSEL TO THE TRANSFEROR TO SUCH EFFECT, THE SUBSTANCE OF WHICH SHALL BE REASONABLY ACCEPTABLE TO THE COMPANY. THIS NOTE MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT OR OTHER LOAN SECURED BY THIS NOTE.
NOTE PURCHASE AGREEMENTNote Purchase Agreement • September 14th, 2016 • Protea Biosciences Group, Inc. • Pharmaceutical preparations • New York
NOTE PURCHASE AGREEMENT (this “Agreement”) made as of the last date set forth on the signature page hereof between Protea Biosciences Group, Inc. (the “Company”), and the undersigned (the “Lender”).
GUARANTY AGREEMENTGuaranty Agreement • September 14th, 2016 • Protea Biosciences Group, Inc. • Pharmaceutical preparations
This Guaranty (“Guaranty Agreement”) is made and executed as of this 8th day of September 2016 by PROTEA BIOSCIENCES, INC., a Delaware corporation (“Guarantor”), having its principal place of business at 1311 Pineview Drive, Suite 501, Morgantown, WV 26505, in favor of __________, (“Lender”), having its principal place of business at _______________________________________.
